Results 91 to 100 of about 420,990 (225)
Robust-gamma delta(+) T cell expansion in infants immunized at birth with BCG vaccine
Cell-mediated immune responses to BCG vaccine were evaluated in 7-month-old infants vaccinated with intradermal combined BCG and Hepatitis B or intradermal BCG and intramuscular Hepatitis B at birth.
T.N. Mazzola +23 more
core +1 more source
Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. [PDF]
Bacille Calmette-Guérin (BCG) vaccination induces a marked increase in the interferon (IFN)-gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents, but not in Malawian adolescents.
Gorak-Stolinska, P. +45 more
core +1 more source
Still Standing Strong: A Narrative Review of Why BCG Remains Central to Global Tuberculosis Control
Background: Tuberculosis is one of the deadliest infectious diseases in the world. However, the BCG vaccine has shown significant results and remains in use to this day. Objective: This review aims to provide a comprehensive perspective on the resilience
Ardaniel Euprasia Simarmata +2 more
doaj +1 more source
The Effect of Stress, BCG Vaccination,and Combination of Stress-BCG Vaccination to The Ability of Macrophage to Bind with CD4+ T Cells in BALB/c Mice [PDF]
The Effect of Stress, BCG Vaccination,and Combination of Stress-BCG Vaccination to The Ability of Macrophage to Bind with CD4+ T Cells in BALB/c Mice Rahajeng N. Tunjung*, Dwi Pudjonarko** Background.
Tunjung, Rahajeng_N.
core +1 more source
Identity and stability assessment of BCG vaccine by multiplex PCR
Multiplex polymerase chain reaction method was used to assess the stability of 7 seed lots of a substrain Mycobacterium bovis BCG-1, Russia, used for the manufacture of BCG vaccine since 1948 till present.
D. T. Levi +7 more
doaj
The Bacillus Calmette-Guérin (BCG) vaccine contains live attenuated Mycobacte-rium bovis; was first used in humans to prevent tuberculosis (TB) in 1921.
Nagi Elsidig +10 more
doaj +1 more source
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response. [PDF]
BACKGROUND: Tuberculosis (TB) remains a global health problem, with vaccination likely to be a necessary part of a successful control strategy. Results of the first Phase 2b efficacy trial of a candidate vaccine, MVA85A, evaluated in BCG-vaccinated ...
O’Shea, Matthew K. +31 more
core +2 more sources
Past and Present Vaccinations in Sweden
Acta Paediatrica, Volume 115, Issue 11, Page 2505-2510, November 2026.
Sven Arne Silfverdal
wiley +1 more source
Development of a new vaccine for tuberculosis (TB) to replace the BCG vaccine has been hampered by the lack of a preclinical vaccine model that accurately reflects the genetic heterogeneity of the human population. We previously tested both Collaborative
Rocky Lai +9 more
doaj +1 more source
Bacillus Calmette–Guérin (BCG) vaccine is extensively and safely used in children in over 150 countries to protect against tuberculosis (TB). BCG revaccination is increasingly being considered for the protection of adolescents and adults against TB.
M. Natraj +4 more
doaj +1 more source

